Drugs / Olumacostat Glasaretil
Olumacostat Glasaretil
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial · 1 met primary | ||||||
| Phase 1/2 | NCT01936324 | Aug 2013 → Jun 2014 | acne | Dermira, Inc. | Completed | Met primary |
| Phase 21 trial · 1 met primary | ||||||
| Phase 2 | NCT02431052 | Apr 2015 → Apr 2016 | acne | Dermira, Inc. | Completed | Met primary |
| Phase 33 trials · 2 missed | ||||||
| Phase 3 | NCT03127956 | Mar 2017 → Apr 2018 | acne | Dermira, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT03073486 | Feb → Dec 2017 | acne | Dermira, Inc. | Completed | Missed primary |
| Phase 3 | NCT03028363 | Dec 2016 → Nov 2017 | acne | Dermira, Inc. | Completed | Missed primary |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Olumacostat Glasaretil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02431052 ↗ |
| Known as | DRM-01B | ChEMBL registry synonym — accepted as the source's own label CHEMBL3989947 ↗ |
| Known as | DRMO1B | ChEMBL registry synonym — accepted as the source's own label CHEMBL3989947 ↗ |
| Known as | Olumacostat glasaretilo | ChEMBL registry synonym — accepted as the source's own label CHEMBL3989947 ↗ |
| Modality | Small molecule | — CHEMBL3989947 ↗ |
| Route | Topical | “applied twice daily to the face” NCT01936324 ↗ |